GlassScriptPhysician profile
John P Yurkanin
NPI 1144409145
$5,993.41
in general payments reported to CMS, 2019-2025
44 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $518 · 2021: $576 · 2022: $927 · 2023: $1,104 · 2024: $993 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,251 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,251.03 |
| Education | $113.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $937.56 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $457.11 | 2019-2025 | |
| Astellas Pharma US INC | $454.32 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $386.04 | 2023-2025 | Orgovyx |
| Dornier Medtech America, INC | $362.03 | 2025 | Dornier Medtech |
| Blue Earth Diagnostics | $331.45 | 2019-2025 | Posluma |
| Myovant Sciences INC. | $322.85 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $322.35 | 2022-2024 | Prolaris |
| Neotract INC. | $262.09 | 2019-2020 | |
| Boston Scientific Corporation | $234.56 | 2019-2025 | Lithovue Elite, Spaceoar Vue System - 10ml, Moses 550 D\F\L |
| Tolmar, INC. | $169.92 | 2023-2024 | |
| Procept Biorobotics Corporation | $141.49 | 2022-2023 | Aquabeam Robotic System |
| Coloplast Corp | $133.27 | 2019-2024 | Porges Coloplast |
| Tolmar Pharmaceuticals, INC. | $119.14 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $106.67 | 2024-2025 | Provenge |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $102.34 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $91.84 | 2021-2024 | Erleada |
| Amgen INC. | $75.43 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $74.70 | 2019-2023 | Bard Urinary Drainage Bag |
| Hollister Incorporated | $72.44 | 2022-2024 | Infyna Chic |
| Sun Pharmaceutical Industries INC. | $70.70 | 2022 | |
| Rochester Medical Corporation | $66.76 | 2021-2022 | |
| Novo Nordisk INC | $65.51 | 2025 | Rivfloza |
| Ferring Pharmaceuticals INC. | $56.66 | 2024-2025 | Adstiladrin |
| Novartis Pharmaceuticals Corporation | $50.66 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $50.14 | 2020-2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $47.53 | 2024 | |
| Becton, Dickinson and Company | $45.66 | 2025 | Totalis Flexible Endo Kit, Magic3 Go Intermittent Urinary Catheter |
| Urogen Pharma, INC. | $42.43 | 2024-2025 | |
| Convatec INC. | $33.07 | 2021 | |
| Ethicon US, LLC | $30.50 | 2023 | Stratafix |
| Merck Sharp & Dohme LLC | $29.01 | 2024 | Keytruda |
| Integra Lifesciences Corporation | $28.89 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Agiliti Surgical, INC. | $27.36 | 2025 | Sonablate Hifu |
| 180 Medical, INC. | $25.18 | 2024 | Gentlecath Glide |
| Daiichi Sankyo INC. | $24.85 | 2025 | Vanflyta |
| Accord Healthcare, INC. | $22.43 | 2023 | |
| Karl Storz Endoscopy-America | $21.63 | 2019 | |
| Photocure INC | $18.57 | 2019 | |
| Baxter Healthcare | $18.44 | 2024 | Perclot |
| Axonics, INC. | $16.69 | 2024 | Axonics |
| Abc Home Medical Supply, INC. | $16.02 | 2024 | |
| Olympus America INC. | $13.59 | 2020 | |
| Abbvie INC. | $13.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Yurkanin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.